4.8 Review

Engineered tumor cell-derived vaccines against cancer: The art of combating poison with poison

Related references

Note: Only part of the references are listed.
Article Chemistry, Multidisciplinary

Engineering Macrophage Exosome Disguised Biodegradable Nanoplatform for Enhanced Sonodynamic Therapy of Glioblastoma

Tingting Wu et al.

Summary: Sonodynamic therapy (SDT) is a promising cancer treatment modality for glioblastoma (GBM) due to its high tissue penetration and minimal damage to normal tissues. However, the blood-brain barrier (BBB) and hypoxic microenvironment present challenges to SDT efficiency. In this study, a biodegradable nanoplatform (CSI@Ex-A) was developed, which could effectively penetrate the BBB and target cancer cells. The nanoplatform releases hydrogen peroxide (H2O2) and oxygen (O-2) to relieve tumor hypoxia, thereby enhancing the efficacy of SDT.

ADVANCED MATERIALS (2022)

Article Chemistry, Multidisciplinary

Hybrid-Membrane-Decorated Prussian Blue for Effective Cancer Immunotherapy via Tumor-Associated Macrophages Polarization and Hypoxia Relief

Lin Hou et al.

Summary: This study successfully addresses the limitations of tumor-associated macrophages and hypoxia conditions in cancer immunotherapy by developing a hollow mesoporous Prussian blue nanosystem with mannose decoration and hydroxychloroquine adsorption. In vivo experiments demonstrate that this system effectively inhibits tumor growth, induces macrophage polarization, promotes cytotoxic T lymphocytes infiltration, and alleviates hypoxia microenvironment.

ADVANCED MATERIALS (2022)

Article Chemistry, Physical

Curcumin encapsulation in functional PLGA nanoparticles: A promising strategy for cancer therapies

Felipe da Silva Feltrin et al.

Summary: Nanoparticles have shown promise as drug delivery systems for various diseases. Encapsulating curcumin in PLGA nanoparticles can overcome its limitations and improve its anticancer effects. This article summarizes recent strategies for delivering curcumin to different cancer cells using PLGA nanoparticles, discusses targeting strategies and improvements for each cancer cell analyzed, and explores encapsulation techniques.

ADVANCES IN COLLOID AND INTERFACE SCIENCE (2022)

Article Chemistry, Physical

A biodegradable Nano-donut for magnetic resonance imaging and enhanced chemo/photothermal/chemodynamic therapy through responsive catalysis in tumor microenvironment

Shaoqi Guan et al.

Summary: The biodegradable Nanodonut (CMPB-MoS2-PEG) with dual therapeutic functions enhances photothermal therapy and chemotherapy through responsive catalysis in the tumor microenvironment. The Nanodonut shows improved photothermal conversion efficiency and excellent biological safety in tumor treatment.

JOURNAL OF COLLOID AND INTERFACE SCIENCE (2022)

Article Chemistry, Multidisciplinary

Non-viral vectors for RNA delivery

Yi Yan et al.

Summary: RNA-based therapy is a promising strategy for disease treatment, and recent advances in non-viral delivery systems have shown potential in protecting RNA, facilitating cell internalization, and controlled release of therapeutics.

JOURNAL OF CONTROLLED RELEASE (2022)

Article Biochemistry & Molecular Biology

Polymer Nanoparticle-Mediated Delivery of Oxidized Tumor Lysate-Based Cancer Vaccines

Cristiana Berti et al.

Summary: Cancer vaccination using oxidized tumor lysate delivered by PLGA nanoparticles enhances antigen uptake and dendritic cell maturation. In vitro experiments show activated dendritic cells stimulated autologous PBMCs when cocultured with melanoma cells. In vivo therapeutic vaccination study in mice indicates that animals treated with PLGA nanoparticle-based oxidized tumor lysate survive longer than those treated with free oxidized tumor lysate.

MACROMOLECULAR BIOSCIENCE (2022)

Article Biochemistry & Molecular Biology

Engineered exosomes as an in situ DC-primed vaccine to boost antitumor immunity in breast cancer

Lanxiang Huang et al.

Summary: By loading immunogenic cell death inducers into breast cancer-derived exosomes, a DC vaccine called HELA-Exos was created. HELA-Exos exhibited high efficacy in inducing immune cell death in breast cancer cells and activating immune responses that suppressed tumor growth.

MOLECULAR CANCER (2022)

Article Nanoscience & Nanotechnology

Thermosensitive Hydrogel Incorporating Prussian Blue Nanoparticles Promotes Diabetic Wound Healing via ROS Scavenging and Mitochondrial Function Restoration

Zhao Xu et al.

Summary: Diabetic foot ulcer is a serious complication in diabetes patients, and oxidative stress is thought to be a key driver of the pathogenesis of such ulcers. In this study, researchers synthesized Prussian blue nanoparticles with the ability to efficiently scavenge reactive oxygen species and incorporated them into a hydrogel for the treatment of diabetic foot ulcers.

ACS APPLIED MATERIALS & INTERFACES (2022)

Review Pharmacology & Pharmacy

Nanovaccines with cell-derived components for cancer immunotherapy

Zhouqi Meng et al.

Summary: This review article explores the recent research progress of cell-derived biomimetic nanovaccines for cancer immunotherapy, and discusses the perspectives and challenges associated with the future clinical translation of these emerging vaccine platforms.

ADVANCED DRUG DELIVERY REVIEWS (2022)

Article Immunology

Immunotherapy of Cancer by Targeting Regulatory T cells

Bo-Jin Chen et al.

Summary: Regulatory T (Treg) cells maintain immune homeostasis and play an important role in immune tolerance, autoimmune diseases, infectious diseases, organ transplantation, and tumor diseases. Targeted elimination of Treg cells can activate tumor-specific effector T cells and improve the efficiency of cancer immunotherapy.

INTERNATIONAL IMMUNOPHARMACOLOGY (2022)

Article Oncology

Implications of nanotechnology for the treatment of cancer: Recent advances

Sergey G. Klochkov et al.

Summary: The use of nanoparticles in anticancer drugs improves safety and efficacy, with advantages such as effective targeting, delayed release, increased half-life, and reduced systemic toxicity. Nano-carriers have shown significant improvements in drug delivery compared to traditional administration, but there are still limitations in their clinical use.

SEMINARS IN CANCER BIOLOGY (2021)

Article Biochemistry & Molecular Biology

Emerging Approaches to Functionalizing Cell Membrane-Coated Nanoparticles

Xiangzhao Ai et al.

Summary: The article summarizes the recent advances in the functionalization of cell membrane-coated nanoparticles, focusing on emerging methods such as lipid insertion, membrane hybridization, metabolic engineering, and genetic modification. These approaches provide diverse functions while preserving the natural function of cell membranes, enhancing the adaptability and multifunctionality of the nanoparticles.

BIOCHEMISTRY (2021)

Review Oncology

Advances in the development of personalized neoantigen-based therapeutic cancer vaccines

Eryn Blass et al.

Summary: Immunotherapy has revolutionized cancer treatment with the development of immune-checkpoint inhibitors and personalized neoantigen vaccines. These vaccines trigger specific T cell responses against individual patient's tumors, showing promising tumor-specific immunogenicity and antitumor activity.

NATURE REVIEWS CLINICAL ONCOLOGY (2021)

Review Nanoscience & Nanotechnology

Roles of Microvesicles in Tumor Progression and Clinical Applications

Shuangli Zhu et al.

Summary: Tumor-derived microvesicles play important roles in tumor initiation and progression, and can be utilized for immunotherapy, tumor vaccines, and cancer diagnosis markers. Additionally, they can be used to reverse tumor drug resistance and deliver chemotherapeutic drugs.

INTERNATIONAL JOURNAL OF NANOMEDICINE (2021)

Review Chemistry, Multidisciplinary

Engineered Extracellular Vesicles for Cancer Therapy

Xu Zhang et al.

Summary: Extracellular vesicles (EVs) have shown great potential as a cell-free strategy for cancer therapy, with the ability to be modified and engineered to enhance their therapeutic efficiency and safety. Recent advances have focused on strategies to scale up production, improve cargo-loading, and enhance tumor-targeting of engineered EVs.

ADVANCED MATERIALS (2021)

Article Chemistry, Multidisciplinary

Equipping Cancer Cell Membrane Vesicles with Functional DNA as a Targeted Vaccine for Cancer Immunotherapy

Bo Liu et al.

Summary: Researchers have designed a targeted nanovaccine that can induce DC maturation and trigger strong antitumor immune responses through assembly of functional DNA. Combining CMV-based nanovaccines with immune checkpoint blockade can improve therapeutic responses and generate long-term immune memory.

NANO LETTERS (2021)

Article Nanoscience & Nanotechnology

Immunotherapy of Tumor RNA-Loaded Lipid Nanoparticles Against Hepatocellular Carcinoma

Yake Zhang et al.

Summary: This study demonstrated that nanoparticles loaded with liver cancer cell-derived RNA successfully induced anti-tumor immune responses, highlighting the potential of RNA LNPs as effective antigen-specific vaccines for HCC.

INTERNATIONAL JOURNAL OF NANOMEDICINE (2021)

Review Biochemistry & Molecular Biology

mRNA vaccine for cancer immunotherapy

Lei Miao et al.

Summary: mRNA vaccines have emerged as a promising platform for cancer immunotherapy, showcasing high potency, safe administration, rapid development potentials, and cost-effective manufacturing. However, challenges such as stability, innate immunogenicity, and inefficient in vivo delivery restrict their applications. In addressing these challenges, structural modifications and formulation methods are being researched to enhance the anti-tumor immune response.

MOLECULAR CANCER (2021)

Article Chemistry, Multidisciplinary

Cell-Derived Biogenetic Gold Nanoparticles for Sensitizing Radiotherapy and Boosting Immune Response against Cancer

Xianya Qin et al.

Summary: The biosynthesis of nanomedicine using tumor cells as a basis has shown potential for enhancing radiotherapy sensitivity and promoting immune responses. Au@MC38's intracellular biomineralization and exocytosis process can be regulated by cellular metabolites and other factors, potentially leading to effective immune responses through radio-sensitization. Additionally, the strategy has demonstrated an effective inhibition of primary and metastatic tumors, as well as improving survival benefits when combined with immune checkpoint blockade.

SMALL (2021)

Review Engineering, Biomedical

Recent Advances in Cell Membrane-Derived Biomimetic Nanotechnology for Cancer Immunotherapy

Faisal Raza et al.

Summary: Immunotherapy in cancer treatment is being significantly impacted by advancements in biomimetic nanotechnology. The challenges surrounding cancer nanomedicine have led to a push for innovative approaches, such as biomimetic nanoparticles, to improve the delivery and effectiveness of immunotherapeutics for cancer. These strategies show promise in addressing issues related to the tumor microenvironment, patient heterogeneity, and immunotoxicity.

ADVANCED HEALTHCARE MATERIALS (2021)

Review Oncology

Cancer Stem Cell for Tumor Therapy

Binjie Huang et al.

Summary: Despite various methods applied in clinical tumor treatment, the prognosis remains poor. Targeted therapy has shown potential due to its specificity and efficiency, especially when targeting cancer stem cells (CSCs) which play a crucial role in tumor genesis, development, metastasis, and recurrence. By targeting CSCs, it is feasible to inhibit tumors and improve prognosis, offering a comprehensive understanding of the biological characteristics of CSCs and various targeted strategies for tumor therapy.

CANCERS (2021)

Article Chemistry, Multidisciplinary

Photochemical internalization (PCI)-mediated activation of CD8 T cells involves antigen uptake and CCR7-mediated transport by migratory dendritic cells to draining lymph nodes

Philipp Schineis et al.

Summary: Antigen cross-presentation to cytotoxic CD8+ T cells is crucial for anti-tumor and anti-viral immune responses. Co-encapsulation of photosensitizers and antigens into microspheres with subsequent photochemical internalization has emerged as a promising strategy. In vivo, dendritic cells take up the microspheres in peripheral tissues and migrate to tissue-draining lymph nodes for CD8+ T cell priming.

JOURNAL OF CONTROLLED RELEASE (2021)

Article Engineering, Biomedical

Cyclophosphamide loaded thermo-responsive hydrogel system synergize with a hydrogel cancer vaccine to amplify cancer immunotherapy in a prime-boost manner

Fan Yang et al.

Summary: Neoantigen-based cancer vaccines have great potential in cancer immunotherapy, but face challenges such as antigen identification, immunogenicity, and immune response. A combined immunotherapy strategy based on PLEL hydrogel is designed in this study, which effectively inhibits tumor growth and prolongs survival by promoting anti-tumor immune responses through a series of injections.

BIOACTIVE MATERIALS (2021)

Review Biochemistry & Molecular Biology

mRNA therapeutics in cancer immunotherapy

Jan D. Beck et al.

Summary: Synthetic mRNA serves as a versatile template for protein synthesis and has a wide range of pharmaceutical applications, including cancer immunotherapy. Strategies such as stimulating pattern recognition receptors and nucleoside modification enhance the effectiveness and safety of mRNA vaccines.

MOLECULAR CANCER (2021)

Review Chemistry, Multidisciplinary

Nanovaccine-Based Strategies to Overcome Challenges in the Whole Vaccination Cascade for Tumor Immunotherapy

Lin Qin et al.

Summary: Emerging NBI strategies aim to enhance the efficacy of nanovaccines in each step of the LDIMP cascade by addressing challenges at five critical cascading events; in the fight against cancer, a balance between each step must be optimized through delicate design and modification of nanovaccines, combined with complementary approaches to provide a synergistic immunity.

SMALL (2021)

Review Medical Laboratory Technology

Development of oncolytic viruses for cancer therapy

Noraini Abd-Aziz et al.

Summary: Oncolytic virotherapy is a therapeutic approach that utilizes replication-competent viruses to selectively kill cancer cells, but it faces limitations such as viral delivery, tumor penetration, and antiviral immune responses. Strategies to overcome these limitations are crucial for its effective application in preclinical and clinical trials.

TRANSLATIONAL RESEARCH (2021)

Review Pharmacology & Pharmacy

Hitchhiking on Controlled-Release Drug Delivery Systems: Opportunities and Challenges for Cancer Vaccines

Lu Han et al.

Summary: Cancer vaccines show promise in fighting cancer, but their clinical efficacy is limited by delivery issues and the need for multiple injections. Controlled-release drug delivery systems can address these challenges, improving vaccine safety and effectiveness.

FRONTIERS IN PHARMACOLOGY (2021)

Article Oncology

MYC oncogene is associated with suppression of tumor immunity and targeting Myc induces tumor cell immunogenicity for therapeutic whole cell vaccination

Xiaofang Wu et al.

Summary: The study demonstrates that targeting the MYC oncogene can induce tumor cell immunogenicity and combining Myc-suppressed whole tumor cells with checkpoint therapy may be used to develop personalized therapeutic tumor vaccines. Analysis of immune phenotypes in human neuroblastoma and melanoma tumors shows that MYCN or c-MYC amplified tumors are associated with suppressed immune cell infiltrates and functional pathways. Targeting Myc in cancer cells with I-BET726 and JQ1 leads to cell cycle arrest and increases cell immunogenicity, while combining vaccination of Myc-inhibited tumor cells with checkpoint inhibition induces robust antitumor immunity in mouse neuroblastoma tumors. Despite vigorous antitumor immunity in the mouse melanoma model, upregulation of immunosuppressive pathways enables tumor escape.

JOURNAL FOR IMMUNOTHERAPY OF CANCER (2021)

Article Engineering, Biomedical

Engineered exosome-like nanovesicles suppress tumor growth by reprogramming tumor microenvironment and promoting tumor ferroptosis

Shichuan Hu et al.

Summary: In this study, fibroblast activation protein-alpha (FAP) gene-engineered tumor cell-derived exosome-like vesicle vaccines (eNVs-FAP) were developed as a candidate tumor vaccine targeting both the tumor parenchyma and the stroma. The eNVs-FAP vaccine showed excellent antitumor effects by inducing strong and specific CTL immune responses against tumor cells and FAP +CAFs, and reprogramming the immunosuppressive TME in various cancer models. The mechanistic analysis revealed that eNVs-FAP promoted DC maturation, increased effector T cell infiltration, and reduced immunosuppressive cell populations in the TME, leading to enhanced tumor cell ferroptosis.

ACTA BIOMATERIALIA (2021)

Review Pharmacology & Pharmacy

Extracellular vesicles as antigen carriers for novel vaccination avenues

Mina Mehanny et al.

Summary: EVs and MVs provide innovative avenues for safe and effective antigen delivery, with potential applications in anti-cancer vaccination immunotherapy and prophylactic vaccination against infectious diseases.

ADVANCED DRUG DELIVERY REVIEWS (2021)

Review Nanoscience & Nanotechnology

Tumor-Derived Extracellular Vesicles: Their Role in Immune Cells and Immunotherapy

Qi Li et al.

Summary: The article discusses the effects of tumor-derived extracellular vesicles on immune cells and summarizes their research progress in tumor immunotherapy and diagnosis.

INTERNATIONAL JOURNAL OF NANOMEDICINE (2021)

Article Immunology

Optimization of Whole Tumor Cell Vaccines by Interaction with Phagocytic Receptors

Mladen Korbelik

Summary: The main function of whole-cell cancer vaccines is the ingestion of tumor antigen-containing material by the patient's antigen-presenting cells. Blocking specific phagocytic receptors may eliminate the therapeutic efficacy of the vaccine, while blocking certain inhibitory receptors could enhance tumor control by the vaccine. This study establishes a potential strategy for enhancing the therapeutic effects of PDT-generated (and possibly other) whole-cell tumor vaccines.

VACCINES (2021)

Article Materials Science, Biomaterials

A simple and general strategy for postsurgical personalized cancer vaccine therapy based on an injectable dynamic covalent hydrogel

Zhentao Yu et al.

Summary: The study introduces a dynamic covalent hydrogel-based vaccine for personalized postsurgical management of tumors, using proteins extracted from resected tumors as antigens. Subcutaneous injection of DCHVax recruits dendritic cells and elicits robust tumor-specific immune responses, effectively inhibiting postoperative growth of residual tumors in murine tumor models. This simple and personalized method shows promise for developing clinically relevant strategies for postoperative cancer treatment.

BIOMATERIALS SCIENCE (2021)

Review Oncology

Therapeutic cancer vaccines

Mansi Saxena et al.

Summary: Therapeutic cancer vaccines aim to induce tumor regression, eradicate minimal residual disease, establish lasting anti-tumor memory, and avoid non-specific or adverse reactions. However, challenges arise due to tumor-induced immunosuppression and immunoresistance, hindering the achievement of these goals.

NATURE REVIEWS CANCER (2021)

Review Chemistry, Multidisciplinary

Cell primitive-based biomimetic functional materials for enhanced cancer therapy

Guo-Feng Luo et al.

Summary: Cell primitive-based functional materials combining natural substances and nanotechnology have emerged as attractive therapeutic agents for cancer therapy. The review summarizes the recent advances in the development of these materials for precise cancer therapy, including different types of cell primitives and strategies for combining them with synthetic materials. Future challenges and perspectives in this field are also discussed.

CHEMICAL SOCIETY REVIEWS (2021)

Article Chemistry, Multidisciplinary

Biomimetic cytomembrane nanovaccines prevent breast cancer development in the long term

Long Xiao et al.

Summary: The researchers have developed a biomimetic cytomembrane cancer nanovaccine named CCMP@R837, which enhanced the immune response against breast cancer cells and established immune memory in BALB/c mice. This vaccine platform shows potential as a candidate for preventive cancer vaccines in clinical settings.

NANOSCALE (2021)

Article Pharmacology & Pharmacy

Cell-derived biomimetic nanocarriers for targeted cancer therapy: cell membranes and extracellular vesicles

Aixue Li et al.

Summary: Nanotechnology provides synthetic carriers for cancer drug delivery, while cell-derived biomimetic vehicles based on the concept of 'mimicking nature' offer low immunogenicity, long circulation time, and targeting ability. Cell membrane-coated carriers and extracellular vesicles are two widely used cell-based biomimetic materials in targeted cancer therapy, but they also face future challenges and development prospects.

DRUG DELIVERY (2021)

Article Chemistry, Multidisciplinary

Tumor Cell Membrane-Coated Liquid Metal Nanovaccine for Tumor Prevention

Yu Zhang et al.

CHINESE JOURNAL OF CHEMISTRY (2020)

Review Pharmacology & Pharmacy

Application of PLGA nano/microparticle delivery systems for immunomodulation and prevention of allotransplant rejection

Sanaz Shahbaz et al.

EXPERT OPINION ON DRUG DELIVERY (2020)

Review Immunology

Advances in Anti-Tumor Treatments Targeting the CD47/SIRPα Axis

Wenting Zhang et al.

FRONTIERS IN IMMUNOLOGY (2020)

Review Chemistry, Multidisciplinary

Biomaterials as Local Niches for Immunomodulation

Kwasi Adu-Berchie et al.

ACCOUNTS OF CHEMICAL RESEARCH (2020)

Review Biotechnology & Applied Microbiology

Improvement, scaling-up, and downstream analysis of exosome production

Davod Jafari et al.

CRITICAL REVIEWS IN BIOTECHNOLOGY (2020)

Article Biotechnology & Applied Microbiology

Exosome-modified PLGA Microspheres for Improved Internalization into Dendritic Cells and Macrophages

Gayeon You et al.

BIOTECHNOLOGY AND BIOPROCESS ENGINEERING (2020)

Article Biotechnology & Applied Microbiology

Macrophage-cancer hybrid membrane-coated nanoparticles for targeting lung metastasis in breast cancer therapy

Chunai Gong et al.

JOURNAL OF NANOBIOTECHNOLOGY (2020)

Article Medicine, Research & Experimental

Neoantigen-based EpiGVAX vaccine initiates antitumor immunity in colorectal cancer

Victoria M. Kim et al.

JCI INSIGHT (2020)

Article Multidisciplinary Sciences

A decade of immune-checkpoint inhibitors in cancer therapy

Caroline Robert

NATURE COMMUNICATIONS (2020)

Review Oncology

Isolation and characterization of exosomes for cancer research

Le Zhu et al.

JOURNAL OF HEMATOLOGY & ONCOLOGY (2020)

Review Biochemistry & Molecular Biology

Exosome-based immunotherapy: a promising approach for cancer treatment

Zhijie Xu et al.

MOLECULAR CANCER (2020)

Article Materials Science, Biomaterials

Cancer cell membrane-coated gold nanorods for photothermal therapy and radiotherapy on oral squamous cancer

Qiang Sun et al.

JOURNAL OF MATERIALS CHEMISTRY B (2020)

Article Multidisciplinary Sciences

Cytomembrane nanovaccines show therapeutic effects by mimicking tumor cells and antigen presenting cells

Wen-Long Liu et al.

NATURE COMMUNICATIONS (2019)

Review Oncology

The evolving landscape of 'next-generation' immune checkpoint inhibitors: A review

Luca Mazzarella et al.

EUROPEAN JOURNAL OF CANCER (2019)

Review Oncology

Immune checkpoint inhibitors of PD-L1 as cancer therapeutics

Akintunde Akinleye et al.

JOURNAL OF HEMATOLOGY & ONCOLOGY (2019)

Article Biotechnology & Applied Microbiology

ZnO nanocrystals shuttled by extracellular vesicles as effective Trojan nano-horses against cancer cells

Bianca Dumontel et al.

NANOMEDICINE (2019)

Article Multidisciplinary Sciences

Tumor exosome-based nanoparticles are efficient drug carriers for chemotherapy

Tuying Yong et al.

NATURE COMMUNICATIONS (2019)

Article Multidisciplinary Sciences

Red blood cell-derived nanoerythrosome for antigen delivery with enhanced cancer immunotherapy

Xiao Han et al.

SCIENCE ADVANCES (2019)

Review Biotechnology & Applied Microbiology

Delivery technologies for cancer immunotherapy

Rachel S. Riley et al.

NATURE REVIEWS DRUG DISCOVERY (2019)

Review Biotechnology & Applied Microbiology

Extracellular Microvesicles as New Industrial Therapeutic Frontiers

Vivek Agrahari et al.

TRENDS IN BIOTECHNOLOGY (2019)

Article Materials Science, Biomaterials

Polydopamine nanoparticles carrying tumor cell lysate as a potential vaccine for colorectal cancer immunotherapy

Xiaoli Wang et al.

BIOMATERIALS SCIENCE (2019)

Review Pharmacology & Pharmacy

Macrophages as delivery vehicles for anticancer agents

Steen J. Madsen et al.

THERAPEUTIC DELIVERY (2019)

Review Engineering, Biomedical

Customizing poly(lactic-co-glycolic acid) particles for biomedical applications

Edyta Swider et al.

ACTA BIOMATERIALIA (2018)

Review Pharmacology & Pharmacy

Microfluidics for producing poly (lactic-co-glycolic acid)-based Check for pharmaceutical nanoparticles

Xuanyu Li et al.

ADVANCED DRUG DELIVERY REVIEWS (2018)

Review Multidisciplinary Sciences

Personalized vaccines for cancer immunotherapy

Ugur Sahin et al.

SCIENCE (2018)

Article Cell Biology

Personalized cancer vaccine effectively mobilizes antitumor T cell immunity in ovarian cancer

Janos L. Tanyi et al.

SCIENCE TRANSLATIONAL MEDICINE (2018)

Review Pharmacology & Pharmacy

Cell membrane-based nanoparticles: a new biomimetic platform for tumor diagnosis and treatment

Ruixiang Li et al.

ACTA PHARMACEUTICA SINICA B (2018)

Article Engineering, Biomedical

PEGylated tumor cell membrane vesicles as a new vaccine platform for cancer immunotherapy

Lukasz J. Ochyl et al.

BIOMATERIALS (2018)

Review Chemistry, Multidisciplinary

Achieving Controlled Biomolecule-Biomaterial Conjugation

Christopher D. Spicer et al.

CHEMICAL REVIEWS (2018)

Review Chemistry, Physical

Engineering cancer vaccines using stimuli-responsive biomaterials

Yu Zhao et al.

NANO RESEARCH (2018)

Article Multidisciplinary Sciences

TGFβ attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells

Sanjeev Mariathasan et al.

NATURE (2018)

Editorial Material Biochemistry & Molecular Biology

Putting the Immunologic Brakes on Cancer

Jedd Wolchok

Article Chemistry, Multidisciplinary

Platelet-Facilitated Photothermal Therapy of Head and Neck Squamous Cell Carcinoma

Lang Rao et al.

ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2018)

Review Oncology

Re-Emergence of Dendritic Cell Vaccines for Cancer Treatment

Mansi Saxena et al.

TRENDS IN CANCER (2018)

Review Biochemistry & Molecular Biology

RNA Sensors of the Innate Immune System and Their Detection of Pathogens

Nanhua Chen et al.

IUBMB LIFE (2017)

Article Chemistry, Multidisciplinary

Surface engineering tumor cells with adjuvant-loaded particles for use as cancer vaccines

Kawther K. Ahmed et al.

JOURNAL OF CONTROLLED RELEASE (2017)

Article Oncology

STAT3-blocked whole-cell hepatoma vaccine induces cellular and humoral immune response against HCC

Qiuju Han et al.

JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2017)

Article Chemistry, Multidisciplinary

Nanobiotechnology: Cell membrane-based delivery systems

Pengfei Zhang et al.

NANO TODAY (2017)

Article Biotechnology & Applied Microbiology

Cellular uptake and trafficking of antisense oligonucleotides

Stanley T. Crooke et al.

NATURE BIOTECHNOLOGY (2017)

Review Biotechnology & Applied Microbiology

Exosomes in Cancer Nanomedicine and Immunotherapy: Prospects and Challenges

Nicholas L. Syn et al.

TRENDS IN BIOTECHNOLOGY (2017)

Review Oncology

Oncolytic Viruses in Cancer Treatment A Review

Sean E. Lawler et al.

JAMA ONCOLOGY (2017)

Article Chemistry, Multidisciplinary

Nanoparticulate Delivery of Cancer Cell Membrane Elicits Multiantigenic Antitumor Immunity

Ashley V. Kroll et al.

ADVANCED MATERIALS (2017)

Article Biotechnology & Applied Microbiology

Therapeutic efficacy of PD-L1 blockade in a breast cancer model is enhanced by cellular vaccines expressing B7-1 and glycolipid-anchored IL-12

Erica N. Bozeman et al.

HUMAN VACCINES & IMMUNOTHERAPEUTICS (2016)

Article Nanoscience & Nanotechnology

Macrophage Cell Membrane Camouflaged Au Nanoshells for in Vivo Prolonged Circulation Life and Enhanced Cancer Photothermal Therapy

Mingjun Xuan et al.

ACS APPLIED MATERIALS & INTERFACES (2016)

Review Pharmacology & Pharmacy

Extracellular vesicles for drug delivery

Pieter Vader et al.

ADVANCED DRUG DELIVERY REVIEWS (2016)

Review Biochemistry & Molecular Biology

CRISPR/Cas9 in Genome Editing and Beyond

Haifeng Wang et al.

ANNUAL REVIEW OF BIOCHEMISTRY, VOL 85 (2016)

Editorial Material Immunology

Whole tumor cell vaccines for glioma immunotherapy

Cameron S. Field et al.

IMMUNOTHERAPY (2016)

Article Chemistry, Multidisciplinary

Cell membrane-formed nanovesicles for disease-targeted delivery

Jin Gao et al.

JOURNAL OF CONTROLLED RELEASE (2016)

Article Chemistry, Multidisciplinary

Prussian Blue Nanoparticles as Multienzyme Mimetics and Reactive Oxygen Species Scavengers

Wei Zhang et al.

JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2016)

Article Chemistry, Multidisciplinary

Bacteria-Mediated Hypoxia-Specific Delivery of Nanoparticles for Tumors Imaging and Therapy

Cheng-Hung Luo et al.

NANO LETTERS (2016)

Article Cell Biology

Vaccination during myeloid cell depletion by cancer chemotherapy fosters robust T cell responses

Marij J. Welters et al.

SCIENCE TRANSLATIONAL MEDICINE (2016)

Article Cell Biology

Display of GPI-anchored anti-EGFR nanobodies on extracellular vesicles promotes tumour cell targeting

Sander A. A. Kooijmans et al.

JOURNAL OF EXTRACELLULAR VESICLES (2016)

Article Biochemistry & Molecular Biology

Restoration of Immune Responsiveness to Glioma by Vaccination of Mice with Established Brain Gliomas with a Semi-Allogeneic Vaccine

Sebastiano Gattoni-Celli et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2016)

Review Pharmacology & Pharmacy

Non-genetic engineering of cells for drug delivery and cell-based therapy

Qun Wang et al.

ADVANCED DRUG DELIVERY REVIEWS (2015)

Article Oncology

miR-206 inhibits metastasis-relevant traits by degrading MRTF-A in anaplastic thyroid cancer

Wen-Long Zhang et al.

INTERNATIONAL JOURNAL OF ONCOLOGY (2015)

Article Chemistry, Multidisciplinary

Cell membrane-camouflaged nanoparticles for drug delivery

Brian T. Luk et al.

JOURNAL OF CONTROLLED RELEASE (2015)

Editorial Material Oncology

Tumor cell-derived microparticles: a new form of cancer vaccine

Huafeng Zhang et al.

ONCOIMMUNOLOGY (2015)

Article Oncology

Cell-free Tumor Microparticle Vaccines Stimulate Dendritic Cells via cGAS/STING Signaling

Huafeng Zhang et al.

CANCER IMMUNOLOGY RESEARCH (2015)

Review Immunology

Whole Tumor Antigen Vaccines: Where Are We?

Cheryl Lai-Lai Chiang et al.

VACCINES (2015)

Article Chemistry, Multidisciplinary

Neural Stem Cell-Mediated Intratumoral Delivery of Gold Nanorods Improves Photothermal Therapy

Rachael Mooney et al.

ACS NANO (2014)

Article Biochemical Research Methods

Surface Functionalization of Exosomes Using Click Chemistry

Tyson Smyth et al.

BIOCONJUGATE CHEMISTRY (2014)

Article Immunology

Current status of autologous breast tumor cell-based vaccines

Samantha L. Kurtz et al.

EXPERT REVIEW OF VACCINES (2014)

Article Medicine, General & Internal

Inactivation of MYC reverses tumorigenesis

Y. Li et al.

JOURNAL OF INTERNAL MEDICINE (2014)

Article Chemistry, Multidisciplinary

Cancer Cell Membrane-Coated Nanoparticles for Anticancer Vaccination and Drug Delivery

Ronnie H. Fang et al.

NANO LETTERS (2014)

Article Multidisciplinary Sciences

Hypoxia-inducible factors and RAB22A mediate formation of microvesicles that stimulate breast cancer invasion and metastasis

Ting Wang et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)

Article Biotechnology & Applied Microbiology

Biodegradable polylactide microspheres enhance specific immune response induced by Hepatitis B surface antigen

Shaohui Qiu et al.

HUMAN VACCINES & IMMUNOTHERAPEUTICS (2014)

Review Biotechnology & Applied Microbiology

Tumor cell lysates as immunogenic sources for cancer vaccine design

Fermin E. Gonzalez et al.

HUMAN VACCINES & IMMUNOTHERAPEUTICS (2014)

Review Pharmacology & Pharmacy

Exosomes as nucleic acid nanocarriers

Jasper G. van den Boorn et al.

ADVANCED DRUG DELIVERY REVIEWS (2013)

Article Oncology

Exosomes from CIITA-Transfected CT26 Cells Enhance Antitumor Effects

Wen Fan et al.

ASIAN PACIFIC JOURNAL OF CANCER PREVENTION (2013)

Article Pharmacology & Pharmacy

Porous silicon advances in drug delivery and immunotherapy

David J. Savage et al.

CURRENT OPINION IN PHARMACOLOGY (2013)

Article Biotechnology & Applied Microbiology

Systemically Injected Exosomes Targeted to EGFR Deliver Antitumor MicroRNA to Breast Cancer Cells

Shin-ichiro Ohno et al.

MOLECULAR THERAPY (2013)

Article Biochemistry & Molecular Biology

CSF-1R inhibition alters macrophage polarization and blocks glioma progression

Stephanie M. Pyonteck et al.

NATURE MEDICINE (2013)

Article Oncology

Cancer Stem Cell Vaccination Confers Significant Antitumor Immunity

Ning Ning et al.

CANCER RESEARCH (2012)

Review Oncology

Whole Cell Vaccines-Past Progress and Future Strategies

Bridget P. Keenan et al.

SEMINARS IN ONCOLOGY (2012)

Review Immunology

Recent progress in mucosal vaccine development: potential and limitations

Nils Lycke

NATURE REVIEWS IMMUNOLOGY (2012)

Article Hematology

Cellular Mechanisms Underlying the Formation of Circulating Microparticles

Olivier Morel et al.

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2011)

Review Oncology

Autologous Versus Allogeneic Cell-Based Vaccines?

Giorgio Parmiani et al.

CANCER JOURNAL (2011)

Article Biochemistry & Molecular Biology

Introduction of the CIITA gene into tumor cells produces exosomes with enhanced anti-tumor effects

Yeong Shin Lee et al.

EXPERIMENTAL AND MOLECULAR MEDICINE (2011)

Review Oncology

Sipuleucel-T for prostate cancer: the immunotherapy era has commenced

Carlo Buonerba et al.

EXPERT REVIEW OF ANTICANCER THERAPY (2011)

Review Biotechnology & Applied Microbiology

Bio-inspired, bioengineered and biomimetic drug delivery carriers

Jin-Wook Yoo et al.

NATURE REVIEWS DRUG DISCOVERY (2011)

Article Chemistry, Multidisciplinary

Nanoparticulate Cellular Patches for Cell-Mediated Tumoritropic Delivery

Hao Cheng et al.

ACS NANO (2010)

Article Biochemical Research Methods

Mammalian cell transfection: the present and the future

Tae Kyung Kim et al.

ANALYTICAL AND BIOANALYTICAL CHEMISTRY (2010)

Article Biotechnology & Applied Microbiology

Macrophage delivery of therapeutic nanozymes in a murine model of Parkinson's disease

Anna M. Brynskikh et al.

NANOMEDICINE (2010)

Article Biochemistry & Molecular Biology

An autoimmune-mediated strategy for prophylactic breast cancer vaccination

Ritika Jaini et al.

NATURE MEDICINE (2010)

Article Medicine, Research & Experimental

Semi-allogeneic vaccines and tumor-induced immune tolerance

Jin Yu et al.

JOURNAL OF TRANSLATIONAL MEDICINE (2009)

Review Immunology

Membrane vesicles as conveyors of immune responses

Clotilde Thery et al.

NATURE REVIEWS IMMUNOLOGY (2009)

Article Oncology

Whole-cell cancer vaccination: from autologous to allogeneic tumor- and dendritic cell-based vaccines

Tanja D. de Gruijl et al.

CANCER IMMUNOLOGY IMMUNOTHERAPY (2008)

Article Nanoscience & Nanotechnology

Mesoporous silicon particles as a multistage delivery system for imaging and therapeutic applications

Ennio Tasciotti et al.

NATURE NANOTECHNOLOGY (2008)

Review Immunology

Antigens for cancer immunotherapy

Michelle A. Neller et al.

SEMINARS IN IMMUNOLOGY (2008)

Article Medicine, Research & Experimental

Polymer nanoparticles for immunotherapy from encapsulated tumor-associated antigens and whole tumor cells

C. M. Solbrig et al.

MOLECULAR PHARMACEUTICS (2007)

Review Engineering, Biomedical

Synthesis and characterization of PLGA nanoparticles

Carlos E. Astete et al.

JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION (2006)

Review Immunology

Immunization without needles

S Mitragotri

NATURE REVIEWS IMMUNOLOGY (2005)

Review Pharmacology & Pharmacy

Physical methods for gene transfer: Improving the kinetics of gene delivery into cells

S Mehier-Humbert et al.

ADVANCED DRUG DELIVERY REVIEWS (2005)

Review Immunology

Cancer vaccines: Between the idea and the reality

OJ Finn

NATURE REVIEWS IMMUNOLOGY (2003)

Article Biochemistry & Molecular Biology

Tumor-derived exosomes are a source of shared tumor rejection antigens for CTL cross-priming

J Wolfers et al.

NATURE MEDICINE (2001)